Ariadne Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.5M Buy
5,730
+165
+3% +$42.3K 0.66% 30
2026
Q2
$1.4M Buy
5,565
+898
+19% +$193K 0.62% 36
2026
Q1
$1.02M Sell
4,667
-352
-7% -$78.1K 0.46% 50
2025
Q4
$1.15M Sell
5,019
-578
-10% -$132K 0.48% 46
2025
Q3
$1.3M Sell
5,597
-253
-4% -$51.5K 0.58% 39
2025
Q2
$1.19M Sell
5,850
-188
-3% -$34.9K 0.57% 44
2025
Q1
$1.12M Buy
6,038
+100
+2% +$19.4K 0.59% 44
2024
Q4
$1.14M Buy
5,938
+29
+0.5% +$5.33K 0.52% 48
2024
Q3
$1.19M Buy
+5,909
New +$1.1M 0.65% 36

Other funds holding ABBV

Ariadne Wealth Management's ABBV Position: Q3 2026 in Review

Ariadne Wealth Management increased its AbbVie (ABBV) stake by 3% in Q3 2026, buying an estimated $42.3K and bringing the position to 5,730 shares worth $1.5M. The position accounts for 0.66% of the portfolio, ranked #30.

Ariadne Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Ariadne Wealth Management held 5,730 shares of AbbVie worth $1.5M as of Q3 2026.
  • Ariadne Wealth Management bought 165 AbbVie shares in Q3 2026, an estimated $42.3K.
  • AbbVie made up 0.66% of Ariadne Wealth Management's portfolio in Q3 2026, its #30 holding.
  • Ariadne Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Ariadne Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.